Aramark Healthcare

Digital Healthcare

PRNewswire | June 02, 2023

CarepathRx Health System Solutions, a CarepathRx company and portfolio company of Nautic Partners (Nautic), and Evernorth Health Services, a subsidiary of The Cigna Group announced a new strategic partnership and investment by Evernorth in CHSS. The strategic partnership brings together Evernorth's diverse specialty and care expertise with CHSS' robust pharmacy and infusion management capabilities, technology solutions, and health system relationships to improve, expand, and accele...

Health Technology

Atlas Healthcare Partners | June 29, 2022

An industry first cardiovascular-focused ambulatory surgery center (ASC) business has been formed by Atlas Healthcare Partners and MedAxiom. Atlas Healthcare Partners specializes in creating and operating ambulatory surgery centers (ASCs). By increasing access to top-notch, patient-centered heart care in ASCs, Atlas and MedAxiom will improve cardiovascular care as a whole. With its health system and physician partners, Atlas, the fastest-growing firm in the ASC sector, has a highly ...

Health Technology

Netsmart | April 12, 2022

Netsmart announced a partnership with Bamboo Health, a leading provider of data and healthcare IT solutions, to create a comprehensive behavioral health referral network supporting the nationwide effort to respond to the need to implement a 988 crisis management system. Through this strategic technology partnership, Netsmart and Bamboo Health will partner to create one of the most robust crisis management solutions in the market. The integrated solution will expedite access to treatment for t...

GNS Healthcare | July 22, 2020

GNS Healthcare (GNS), a leading AI and simulation company, presents results that validate the use of AI to accurately classify tumors based on their immunogenicity and predict response to immune checkpoint inhibitor (ICI) therapy using real-world data. The study showcases the power of causal AI to capture biomarkers and mechanisms, in addition to PD(L)1 and tumor mutation burden (TMB), that are consistent with known immunology. These markers, including CXCL13 upregulation and STK11 mutation, are...